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Abstract
Background: International recommendations suggest exercise and self-management programs, including
non-pharmacological treatments, for knee osteoarthritis (KOA) because they can benefit pain relief and improve
function and exercise adherence. The implementation of a combined self-management and exercise program
termed PLE2NO may be a good method for controlling KOA symptoms because it encourages the development
of self-efficacy to manage the pathology. This study will assess the effects of a self-management and exercise
program in comparison to an educational intervention (control program) on symptoms, physical fitness, health-related
quality of life, self-management behaviors, self-efficacy, physical activity level and coping strategies.
Methods/Design: This PLE2NO study is a single-blinded, randomized controlled trial of elderly (aged above 60 yrs old)
patients with clinical and radiographic KOA. The patients will be allocated into either an educational group (control) or
a self-management and exercise group (experimental). All participants will receive a supplement of chondroitin and
glucosamine sulfates. This paper describes the protocol that will be used in the PLE2NO program.
Discussion: This program has several strengths. First, it involves a combination of self-management and exercise
approaches, is available in close proximity to the patients and occurs over a short period of time. The latter two
characteristics are crucial for maintaining participant adherence. Exercise components will be implemented using
low-cost resources that permit their widespread application. Moreover, the program will provide guidance regarding
the effectiveness of using a self-management and exercise program to control KOA symptoms and improve
self-efficacy and health-related quality of life.
Trial registration: NCT02562833 (09/23/2015)
Keywords: Self-management, Exercise, Knee osteoarthritis, Elderly
Background
Osteoarthritis (OA) is the most common type of rheum-
atic disease [1]. OA is prevalent in elderly populations and
has a substantial influence on the health care industry [2,
3]. In the USA, 27 million people, including 12.1 % of the
population aged 25–74 years old, are clinically defined as
having OA [4].
OA is an active disease [5] that affects all articular tissues
[6]. OA can be characterized by examining a person’s
symptoms, especially pain [7], which influence the perform-
ance of daily living activities [8] and psychological parame-
ters [3]. Among older adults, OA primarily affects weight
bearing joints, such as the knee and hip, and is therefore a
cause of lower extremity disability [9]. In Portugal, knee
OA (KOA) is considered to be the third most prevalent
rheumatic disease (affecting 12.4 % of the population) [10].
Most types of interventions that are aimed at managing
KOA involve community and primary care [5]. Hence, it is
imperative to consider international recommendations that
can assist individuals and that are feasible alternatives to
health services. The Osteoarthritis Research Society Inter-
national (OARSI) [11], the American College of Rheuma-
tology (ACR) [12] and the European League Against
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Rheumatism (EULAR) [13] strongly recommend exercise
(including land-based, such as strengthening and aerobic
activity or water-based activities) and self-management
programs as non-pharmacological treatments for KOA
patients.
Self-management programs
Patient education, information and self-management sup-
port are critical for patient cooperation during treatment.
Besides OARSI international recommendations (11), sev-
eral evidence-based studies of self-management programs
have demonstrated that it is effective to empower patients
to better manage their own chronic diseases [14–26].
Psychoeducational interventions are growing in popular-
ity in the primary care field [24]. Among these efforts,
self-management programs deserve special attention. The
following three models of chronic disease self-management
programs are the most widely used: the Expert Patient
Programme [27], the Flinders Model [28], and the Stanford
Model [29]. The Expert Patient Programme focuses on
increasing patient knowledge to manage conditions, the
Flinders Model emphasizes the role that physicians play in
building patient self-efficacy, and the Stanford Model uses
peer educators to build self-efficacy [30].
Two programs have followed the format of the Stanford
Model. These include the Arthritis Self-Management Pro-
gram (ASMP) and the Chronic Disease Self-Management
Program (CDSMP) [31, 32]. The first of these, the ASMP,
is a specific program for people with arthritis that was de-
veloped in the 1970s at the Stanford Patient Education Re-
search Center [19]. Later, the same group developed a
more generic proposal for patients with any chronic con-
dition, the CDSMP. This program has now spread in
popularity throughout the US [31, 32] and other countries
[17, 18, 23, 25, 33].
A meta-analysis of the ASMP and the CDSMP [34]
revealed that improvements were observed in several
outcome measures in patients with chronic diseases
at 4 and 12-month follow-ups.
Exercise programs
Studies have demonstrated that exercise benefits patients
with KOA [35–46]. The two most recognized approaches
for KOA treatment with exercise are land-based [47–49]
and aquatic programs [44, 50–53]. A recent systematic re-
view and meta-analysis [54] provided evidence showing
that land-based exercise is beneficial for people with KOA
because it reduced joint pain and improved physical func-
tion and quality of life over the short-term and for at least
two to six months after the cessation of treatment. Re-
garding the exercise mode, studies have demonstrated that
there is no difference between the efficacies of strengthen-
ing, flexibility plus strengthening, flexibility plus strength-
ening plus aerobic exercise, aquatic strengthening, aquatic
strengthening plus flexibility and a combined intervention
that included strengthening, flexibility, and aerobic exer-
cise when each was compared to a no exercise control,
and there were no differences between the effect of the in-
terventions on improving functional limitations in people
with lower limb OA [55]. Additionally, no difference was
observed in the effectiveness of providing pain relief be-
tween strengthening and aerobic exercises across eight
studies that involved KOA patients [56].
Thus, combining aerobic and muscle strengthening
exercises into a single program may produce even better
outcomes in arthritis patients [57] than programs based
on only one of these components. A program that com-
bined aerobic and resistance exercises significantly im-
proved physical function and daily living activities and
reduced pain in older adults with arthritis [40], as well
as decreased depression [36, 49, 58, 59]. Another pro-
gram combined a variety of exercises focused on core
strength and balance, flexibility, upper and lower body
strength and aerobic conditioning and resulted in im-
provements in mobility, aerobic endurance, strength,
flexibility, and self-reported pain perception [35].
Nutritional supplements: glucosamine and chondroitin
sulfate
Although important, controlling symptoms is not the
only target when treating OA patients. Indeed, an ideal
treatment for OA should preserve joint structures, im-
prove quality of life and for drug therapy or supplemen-
tation, have a good safety profile [60]. It is paramount
that the administrator account for side effects that can re-
sult from the chronic use of OA pharmacological therapies,
such as nonsteroidal anti-inflammatory drugs (NSAIDs)
[61]. Therefore, glycosaminoglycans such as chondroitin
sulfate (CS) and glucosamine sulfate (GlcN-S) are two nat-
ural supplements that are considered to be symptomatic
slow-acting drugs for osteoarthritis (SYSADOA) [60].
GlcN-S has been shown to exhibit structure-modifying
effects, including small to moderate protective effects on
minimum joint spaces after 3 years, in KOA patients
[62]. This finding was in agreement with the results of a
previous trial that indicated that GlcN-S prevents total
knee replacement (TKR) [63].
CS has also been evaluated in different clinical trials that
have sought to document both its symptomatic potential
and its structure-modifying effects. A recent study [64]
demonstrated the efficacy of CS for treating symptoms
(i.e., pain and lower-limb function) and concluded that CS
is an efficient and safe intervention. Interestingly, CS pro-
duced a significant reduction in joint swelling and effusion
in a gait study [65].
A double-randomized placebo-controlled clinical trial
with a 2-year follow-up of 605 patients with KOA dem-
onstrated that after adjusting for factors associated with
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structural disease progression, a dietary supplement that
consisted of a combination of GlcN-S and CS resulted in
significantly less joint space narrowing than was observed
with the placebo, whereas neither CS nor GlcN-S alone
was effective [66]. A combination of GlcN-S-hyaluronic
acid (500 mg) and CS (400 mg) was found to be efficient
at providing pain relief and functional improvement in OA
patients with moderate to severe knee pain [65]. These
findings suggested that a combination of GlcN-S and CS
may be more efficient than either CS or GlcN-S alone.
Although some interventions have combined patient
self-management with an exercise component, we were
unable to identify any study that combined these com-
ponents with GlcN-S and CS supplementation.
Aim and hypothesis
The aim of this study is to design and implement a
PLE2NO program (in Portuguese: Free Program of Educa-
tion and Exercise for Osteoarthritis) for elderly patients
with KOA for a duration of three months. The PLE2NO is
based on applying the principle of self-efficacy to manage
the pathology. When patients gain confidence in taking
control of their disease, they are more comfortable exer-
cising and managing OA symptoms and consequently
make better decisions about treatment. This allows them
to increase their quality of life. To encourage participant’s
adherence to and maintenance of the program and to con-
tribute to pain control, all participants will receive a sup-
plement containing CS and GlcN-S.
The following three hypotheses were therefore for-
mulated. H1, self-reported KOA symptoms (i.e., pain
and stiffness) and physical fitness will improve more in
the self-management and exercise group than in the
control group; H2, self-management skills and self-
efficacy will improve more in the self-management and
exercise group than in the control group; and H3, health-
related quality of life, physical activity levels and coping




The PLE2NO is a single-blinded, randomized controlled
trial with a three-month duration and a six-month
follow-up. The participants will be individually randomly
assigned to one of two groups: (1) a self-management
and exercise group or (2) an educational control group.
Both groups will receive supplementation (CS and
GlcN-S). Figure 1 provides a flowchart of the PLE2NO
design. It will not be possible to blind the participants
because of the nature of the intervention. However, the
assessors will be blinded to group allocation.
Sample size
The sample size was calculated based on the primary
outcome (self-reported pain). The analysis were done by
the program GPower 3.1 [67], based on a priori analysis
with ANCOVA, using one covariate and two groups
with 80 % power at a 5 % significance. According to
McKnight’s study [68], a combined strength training and
a self-management program, we fixed the effect size on
0.35 and determined we needed a total sample size of
67. Considering a possible dropout of 20 %, we aimed to
recruit 80 subjects and allocated 40 subjects per group.
Participants and procedures
The recruitment and selection processes will be per-
formed using the following eligibility criteria: (1) an age
of 60 years old or older, (2) bilateral or unilateral KOA
diagnosed according to the clinical and radiological cri-
teria of the American College of Rheumatology (ACR)
[69], and (3) participants who are independently mobile
and literate. The exclusion criteria will be the following:
(1) involvement in another intervention program (exer-
cise, education or physical therapy), (2) the prior use of
supplements (chondroitin and/or glucosamine sulfate)
for at least three months, and (3) other pathologies (e.g.,
cardiovascular, respiratory, and musculoskeletal pathologies
and cancer) that prevent the practice of physical exercise,
(4) a mental/psychological state that hinders understanding
the program, (5) surgery for knee replacement or a plan to
undergo surgery to place a prosthesis within the next eight
months, (6) an allergy to shellfish or another component of
the supplements, and (7) administration (injections) of cor-
ticosteroids or hyaluronic acid in the last 6 months.
To avoid convenience sampling, the participants will
be recruited from the Lisbon area, and different market-
ing strategies will be used to advertise and publicize the
PLE2NO program. Social networks, newspapers, maga-
zines, contacts with senior universities, health centers,
churches and community centers, and the site of the
Portuguese League Against Rheumatic Disease will be
the main channels used for PLE2NO announcements.
All individuals interested in participating will be invited
to an awareness session in which the details of the pro-
gram will be explained, and the patients will complete an
eligibility questionnaire, which is necessary to acquire
more detailed information, including whether they have
any allergies to components in the supplements. As many
sessions as necessary will be performed until the expected
sample size is attained. Anyone who is interested and
fulfills the eligibility criteria will receive a request for an
x-ray examination. The exam requests will be referred to a
rheumatologist who will make the final diagnosis accord-
ing to the ACR clinical and radiological criteria. This is a
more specific diagnosis (86 %) than a simple clinical diag-
nosis (69 %) [70]. If the subject is found to be positive for
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KOA, he or she will be invited to a second interview dur-
ing which consent will be obtained.
The randomization process will be performed on the
baseline assessment day by the research team leader.
The randomization sequence will be a 1:1 allocation to
the two treatment arms.
Interventions
The active treatment group will engage in self-management
and exercise (SMEG), and the control group will engage in
patient education (EG) only. The SMEG patients will re-
ceive a combination program including self-management
and exercise that will be delivered on the same days twice
per week. Each session will last 90 min. The first 30 min
will be allocated for self-management, and the remaining
60 min will be used for exercise. The program will be of-
fered in a group format that encourages interaction and
socialization, which can help to counteract feelings of de-
pression and isolation. To avoid any conflict of interest and
because we believe that it will help support the participants’
adherence, maintenance and pain control, all participants
will receive a supplement that consists of a combination of
two main substances: 1500 mg of glucosamine sulfate and
1200 mg of chondroitin sulfate, in addition to two second-
ary substances: 100 mg of Harpagophytum extract and
10 mg of hyaluronic acid. The recommendation is to use
two packets per day. The participants themselves will have
to complete daily sheets that request information regard-
ing pain levels that are assessed on a visual numeric pain
scale [71] and a bi-daily supplementation diary. All partici-
pants will be covered by personal accident insurance.
Self-Management and Exercise Group (SMEG)
Self-management component
The self-management component is based on a program
that was developed at Stanford University, the Chronic
Disease Self-Management Program (CDSMP) [32], which
aims to develop self-efficacy and emphasizes skills mas-
tery. These are accomplished through the weekly perform-
ance of specific behaviors and the receipt of feedback
Fig. 1 The PLE2NO flowchart
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(action plan and problem solving). The contents of the
program will include the following: self-management prin-
ciples, managing symptoms, exercise and physical activity,
communication skills, healthy eating, and managing medi-
cines. The program will be administered by a certified
Master Trainer and Leader of the CDSMP at Stanford
University.
Exercise component
The exercise component is based on the Fit and Strong
Program [72], Exercise for People with Arthritis (FEPA)
[35] and the Taking Control with Exercise (Arthritis
Foundation) program. This exercise program contains
health-related (muscular resistance/strength, and flexibil-
ity) and skill-related (balance) physical fitness compo-
nents. Additionally, the program will include socialization
games that help to decrease symptoms related to pain,
stress, depression, and fatigue. In addition to improve-
ments in physical fitness, the development of self-efficacy
in exercise is another goal.
The exercise session type includes a warm up for the
first 5 min, followed by 15 to 20 min of recreation activ-
ity and balance exercise, 30 to 40 min of the strengthen-
ing exercises, and 10 to 15 min of stretching and
relaxation exercises at the end.
Specific strength exercises will be performed to recruit
specific muscle groups in the lower limbs (quadriceps,
hamstrings, hip adductors/abductors, gluteus, and gastro-
cnemius) and the upper limbs (pectoralis, trapezius, dor-
sal, deltoids, biceps and triceps). The strength exercises
will use a combination of elastic bands (upper limbs) and
cuff weights (lower limbs) or calisthenics, as previously
used in other studies [73, 74] and replicated in the Fit and
Strong program [72]. The resistance will be progressively
increased throughout the program by adding weights in
increments of 0.250 Kg to the cuff weights. The progres-
sions in the numbers of repetitions and series are illus-
trated in Table 1.
The prescribed intensity and management of exercise
resistance will be primarily guided by answers related to
self-reported pain, which will be assessed using a Visual
Numeric Pain Scale [71] before, during and after each
session. At the beginning of each session, all participants
will be required to present their pain diaries. If the pain
level is above five points on the day before the last ses-
sion, the load will not be increased, but if pain is below
five points, they patients will receive increased loads.
The intensity interval desired for strengthening exercises
will be maintained at 4-6 (somewhat easy – somewhat
hard) according the Omni-Perceived Exertion Scale for
Resistance Exercise (OMINI-RES) [75].
This component will be overseen by a professional
with a master’s degree in Science of Physiotherapy and
another individual who is an Exercise and Health mas-
ter’s student. Both will be from the Faculty of Human
Kinetics.
To develop exercise self-efficacy and promote the main-
tenance of the exercise program before the end of the
class, a chart with the main exercises for each physical fit-
ness component (i.e., muscular resistance/strength, flexi-
bility, and balance) will be given to the participants during
the last two weeks of the intervention program. The par-
ticipants will be encouraged to perform the exercises by
themselves by following the chart during the last two
weeks with supervision from the same professionals that
conducted the exercise program. It is expected that they
will develop the capacity to perform the exercises by
themselves in their homes without supervision by the end
of the intervention.
Education control Group (EG)
This group will receive a book [76] published by PLE2-
NO’s scientific team. This book contains descriptions and
tips for managing KOA in addition to educational and ex-
ercise information presented as images. Additionally, the
participants will attend three monthly educational sessions
that are one hour in length each regarding joint protection
strategies, exercise, and self-management techniques.
These sessions will be delivered by the coordinator of the
PLE2NO project, who is a PhD Professor in the Faculty of
Human Kinetics, and an Exercise and Health master’s stu-
dent from the same institution. Telephone contacts will
be established 15 days after each educational session to
avoid withdrawals and to maintain closer monitoring.
Assessments and procedures
The assessments will be performed one week prior to the
start of the program (baseline), during the week following
the final intervention (three months later), and at a 6-
month follow-up, and will be done by PLE2NO team
member(s) (all of whom are master students in exercise
and health specialties) who are blinded to group allocation.
Table 1 Training volume
Week 1-3 Week 4-6 Week 7-9 Week 10-12
No additional load Load 1 Load 2 Load 3
Week 1: 1 × 12 rep Week 4: 1 × 12 rep Week 7: 1 × 12 rep Week 10: 1 × 12 rep
Week 2: 2 × 8 rep Week 5: 2 × 8 rep Week 8: 2 × 8 rep Week 11: 2 × 8 rep
Week 3: 2 × 12 rep Week 6: 2 × 12 rep Week 9: 2 × 12 rep Week 12: ×12 rep
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Each evaluator performs the same test to avoid inter-rater
variability. The assessments will be performed on the same
day. To avoid overloading the participants, the physical
tests and questionnaires will be performed alternately.
Additionally, the physical tests involving load-bearing ac-
tivities will be alternated with those that are performed
while seated. The order of those tests and questionnaires
were determined previously, in accordance with the state-
ments already mentioned.
The main outcome will be self-reported pain (sub-
score of the Knee Injury and Osteoarthritis Outcome
Score –KOOS). The secondary outcomes will be: other
KOA symptoms, KOA-specific health-related quality of
life, self-efficacy, self-management behaviors, a healthier
quality of life, a physically active lifestyle, coping strat-
egies, aerobic capacity, functional strength, mobility,
flexibility, gait speed, static balance and handgrip. All
outcomes and instruments are illustrated in Table 2 and
will be assessed at baseline, post-intervention and a 6-
month follow-up.
Eligibility questionnaire
This questionnaire collects personal data (including
name, phone contact, address, and email) and the inclu-
sion and exclusion criteria for participation in the pro-
gram. It will be available both online and on paper.
X-ray
Bilateral, anterior-posterior knee radiographs will be
used to identify OA in the tibiofemoral joint, and sunrise
views will be used to identify OA in the patellofemoral
compartment. The severity of OA in the tibiofemoral
and patellofemoral joint will be measured by a rheuma-
tologist using the K-L grading scale [77].
Socio-demographic information
A questionnaire will be created by the researchers that
poses demographic questions, including date of birth, race,
sex, marital status, current occupation, occupation before
retiring and education level. Body mass index (BMI) will
also be calculated as weight (measured in kilograms) over
height squared (height measured in meters).
Use of medicine
A list containing the names of all medications being
used and their doses and indications will be requested
from the patients before and after the intervention
(baseline and post-intervention).
Questionnaires
Knee Injury and Osteoarthritis Outcome Score (KOOS)
This questionnaire includes 5 dimensions to measure
KOA-specific health-related quality of life (QOL), knee
pain (Pain), other disease-specific symptoms (Other Symp-
toms), daily living activities (ADL), and sport/recreation
functions (Sport/Rec). A score for each of the five dimen-
sions is calculated as the sum of the items that are in-
cluded, which is then converted to a 0–100 scale in which
0 represents extreme knee problems and 100 represents
no knee problems. The KOOS has been validated for use
in patients with knee injuries and patients with KOA and
is a reliable and responsive self-administered instrument
for short-term follow-ups [78].
Self-efficacy for managing chronic disease 6-item scale
This 6-item scale contains items taken from several self-
efficacy scales that were developed for the Chronic Disease
Self-Management study. This is a one to ten scale that in-
cludes six questions. The scale was tested on 605 subjects
with chronic diseases [31]. The observed range of out-
comes was 1-10 with a mean of 5.17, a standard deviation
of 2.22, and an internal consistency reliability of 0.9.
Cognitive symptom management
This scale comprises six questions and has an observed
range of 0–5. The scale was tested on 1129 subjects with
chronic disease, and 51 of these subjects who underwent
a test-retest protocol [79]. The mean result was 1.33
with a standard deviation of 0.91, an internal consistency
reliability of 0.75 and a test-retest reliability of 0.83.
Table 2 Outcomes and instruments
Outcomes Instruments
Questionnaires KOA-specific health-
related quality of life
Knee Injury and Osteoarthritis
Outcome Score (KOOS)
Self-efficacy Self-efficacy for managing








Euroquol five dimensions five
level (EuroQol -EQ-5D-5L)
Physical activity International Physical Activity
Questionnaire (IPAQ)
Coping strategies Brief COPE
Physical fitness
tests
Aerobic Capacity Six-Minute Walking Test (6 MWT)
Functional lower-
limb strength
Five-Repetition Sit to Stand Test
(FRSTST)
Mobility Timed “Up-and-Go” test
Flexibility upper limb Back Scratch Test (BST)
Flexibility lower limb Chair Sit and Reach (CRS)
Gait speed 6-Meter Test
Balance Standing Balance
Hand strength Hand grip test
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Communication with physicians
This questionnaire includes three questions. The scale
was tested on 1130 subjects with chronic disease, and 51
of these subjects underwent a test-retest protocol [79].
The results showed an observed range of 0–5, a mean of
3.08, a standard deviation of 1.20, an internal consistency
reliability of 0.73 and a test-retest reliability of 0.89.
Perception of health and quality of life (EuroQol - EQ-5D-5 L)
The EQ-5D-5L is a generic instrument for measuring
health-related quality of life (HRQoL) that allows the
generation of an index that represents a status value of
the health of an individual. This scale is based on a clas-
sification system that describes health along the following
five dimensions: mobility, personal care, usual activities,
pain/discomfort, and anxiety/depression. Each of these
dimensions has five levels of severity. This instrument
employs psychometric techniques similar to those of
the EQ-5D [80].
International Physical Activity Questionnaire (IPAQ)
The short form of the IPAQ was chosen because it is
easy to apply. Its reliability has been verified in many
countries and in different populations [81, 82].
Brief COPE
The first version of the COPE inventory by Carver, Scheier
and Weintraub [83] was subsequently abbreviated by
Carver [84]. The abridged version (brief COPE) contains
only 28 items that are answered on a Likert 4-point scale
(ranging from 1 = never use this strategy to 4 = I often use
this strategy) and divided into the following 14 sub-scales
(two items per scale): active coping, denial, substance use,
emotional support, instrumental support, behavioral di-
vestment, ventilation, revaluation, planning, mood, ac-
ceptance, religion, and self-blame. Data from a study of
survivors of Hurricane Andrew indicate that the brief
COPE scales have an adequate internal reliability [84].
Physical fitness tests
Six-Minute Walk Test (6 MWT)
This test is a valid measure of aerobic capacity in older
adults [85], and it has been used in studies of KOA [86, 87].
Five-Repetition Sit to Stand Test (FRSTST)
This measure is a widely used measure of functional
strength. The ICC values for this test reveal good to high
test-retest reliability for adults and subjects with osteo-
arthritis [86, 88, 89].
Timed “up-and-go”
This is a test of strength, agility and dynamic balance
that incorporates multiple activity themes. The time
(seconds) taken to rise from a chair, walk 3 m (9 ft, 10
inches), turn, walk back to the chair and then sit down
wearing regular footwear (while using a walking aid if re-
quired) is assessed [90].
Chair Sit and Reach test (CSR)
The CSR test is a safe and socially acceptable alternative
to traditional floor sit-and-reach tests and is a reasonably
accurate and stable measure of hamstring flexibility [91].
The subjects are allowed three attempts for each limb,
and the best of these scores is recorded to the nearest
centimeter.
The Back Scratch Test (BST)
The BST is a measure of overall shoulder range of mo-
tion. This test involves measuring the distance, using a
ruler, between (or overlap in) the middle fingers when
they are placed behind the back [92]. After a practice
trial, this test is assessed twice, alternating between both
hands, and the best value is registered for each.
Six-meter test
This test measures linear walking ability, excluding ac-
celeration and deceleration [93]. This variable is also
used as a primary outcome in an algorithm for sarcope-
nia in older individuals [94].
Standing balance test
This test will be performed bilaterally. While near a wall,
the subject crosses theirs arms over their chest, lifts the
preferred leg off the floor without touching the other
leg, and holds this position with their eyes open as long
as possible. Contact between the legs, the support touch-
ing the ground, touching the wall and withdrawing the
arms from the chest are considered errors. The evaluator
stops recording the time upon the occurrence of any
error. The participants will perform two repetitions of
the test, and the best result will be recorded [95].
Hand Grip Test (HGT)
This test evaluates the maximal isometric force exerted
by the muscles of the hand and forearm using a dyna-
mometer. Although this study will not examine hand
OA, this test has been used in the elderly as an indicator
of sarcopenia and/or disability [96, 97]. Prior to the test,
the grip dynamometer will be adjusted to the size of the
hands of each subject. The subjects will stand with their
arms along their bodies without contact with their trunk
and with their elbows slightly bent at a 20° angle. Test-
ing will first be conducted using the dominant hand and
subsequently using the non-dominant hand. Strength
will be evaluated during the expiratory phase to avoid
the Valsalva maneuver. The best of three repetitions will
be chosen for further analysis.
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Other measures
Patient’s Global Impression of Change (PGIC)
This scale is often used in clinical research, particularly
in musculoskeletal studies [98]. The changes will be clas-
sified on dichotomous scales, and the classifications that
will be used will include perceived change (5–7), an ex-
perience reflecting significant changes (1–4) and a lack
of experience reflecting significant changes [98].
Visual Numeric Pain Scale (VNS)
This scale is used to self-report pain. It combines strong
visual cues with an 11-point numeric rating scale. The
VNS is highly correlated with the visual analogue scale
(VAS, r = 0.85), is sensitive to changes in pain, and has
been demonstrated to be a valid measure [71].
OMNI resistance exercise scale
This scale is a perceived exertion scale used with resist-
ance exercise, and its high level of construct validity indi-
cates that the OMNI-RES measures the same properties
related to exertion as the Borg RPE scale [99] during re-
sistance exercise [75].
Data analysis
The data will be analyzed in a blinded manner. Descriptive
statistics will be used to describe subject characteristics.
The intervention and control groups will be examined for
baseline comparability with respect to demographic and
other factors. Kolmogorov-Smirnov tests will be used to
test for normality. Univariate analyses of covariance
(ANCOVA) will be conducted to compare changes be-
tween groups (i.e., the self-management and exercise
group compared to the educational group) with adjust-
ments for baseline values. The mean difference within
groups will be calculated as Mom 1 (baseline) minus
Mom 2 (after intervention program). The effect sizes
will be verified using partial eta squared statistics. Re-
peated measures analyses using linear mixed models
will be used to assess the constancy of any effects in
the self-management and exercise group over time.
Missing data will be assumed to be missing at random.
All statistical analyses will be performed using IBM
SPSS Statistics 22.0 and MedCalc Statistical Software
(MedCalc Software, Mariakerke, Belgium), and signifi-
cance will be established at a level of 5 %.
Discussion
It is essential to identify the best approach to treating
patients with KOA. Such an approach should consider
the individuals’ quality of life, international recommen-
dations for treatment and the availability of health ser-
vices. Therefore, the combined use of self-management,
exercise and supplements (glucosamine and chondroitin
sulfate) appears to be a feasible and effective option for
treating elderly patients with KOA.
There are several strengths to the design and implemen-
tation of this study protocol. First and foremost, this pro-
gram combines the recommendations of international
organizations (OARSI, EULAR and ACR) with a combin-
ation of exercise and educational (self-management) pro-
grams. The study design is extremely current, ambitious
and grounded.
Second, the program will be administered in close prox-
imity to the patients. To achieve this goal, the program
will take place at four different locations: two senior uni-
versities, one church, and one community center. This is
necessary because when we consider the age and patho-
logical conditions that we expect to find in the study pa-
tients, locomotion may be a barrier. Therefore, if a patient
will not be able attend for financial reasons, a van from a
church or a team member’s car will provide transportation
services. These efforts will minimize the problem of access
to the classes.
Third, the methodology of the program, in terms of
both self-management and exercise, has been planned in
extreme detail using simple resources, including paper
roles for the self-management component and elastic
bands, ankle weights and chairs for the exercise compo-
nents. Thus, the program can be feasibly disseminated
(e.g., it uses minimal, low-cost equipment and has few
storage requirements). The exercise program will be ad-
ministered by highly qualified exercise instructors, two
of whom have master’s degrees in Sport Science and the
Science of Physiotherapy, and one other instructor who is
an Exercise and Health master’s student from the Faculty
of Human Kinetics. All of these instructors specialize in
exercise, health and fitness group skills. Furthermore, a
certified leader of the Chronic Disease Self-Management
Program (CDSMP) at Stanford University will administer
the self-management program.
The program will also have a self-efficacy component
for exercise, with a goal that following the end of the
program, the patients will continue doing exercises, and
they will receive support in this endeavor, including ac-
cess to the materials that were used in the program, a
chart with a description of all of the exercises that they
performed in class and a brief explanation about how
these exercises should be performed.
With the exception of the knee radiographs for the
OA diagnoses, all measurements will be obtained at
the same place at baseline immediately after the end of
the program and at the 6-month follow-up. Therefore,
to support the project, the staff team includes one sec-
retary who is responsible for the administrative work
and four health professionals who will conduct the
tests and questionnaires. To avoid inter-rater error, the
same health professionals will lead the applications of
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the three assessments, i.e., the baseline, post-intervention
and follow-up assessments.
Participant adherence to the exercise program is one
of the main challenges, mainly because the participants
are elderly and susceptible to other health problems.
Therefore, motivational cues, intragroup social interac-
tions, frequent telephone calls and the quality of the
professors are the main strategies that have been se-
lected to prevent the occurrence of dropouts.
One possible constraint to the success of the program
is the extensive exclusion criteria, but these criteria are
required to maintain the quality of the study. In this
study, all adverse events will be documented and re-
ported from screening until study completion.
Our study is based on the premise that elderly patients
with KOA need an appropriate treatment regimen that is
accessible and achievable, given their condition. Therefore,
the study treatment regimen was designed to develop their
self-efficacy to manage their own condition. The concepts
of autonomy, self-management and self-efficacy are there-
fore essential. Moreover, once the program ends, the par-
ticipants are expected to continue the treatment using
self-management skills and by performing the exercises
on their own, which should consequently assist them in
coping better with pain and KOA symptoms.
The findings of this study will contribute to clinical trial
reference data for elderly individuals with KOA by adding
information regarding the effectiveness of combining a
self-management strategy with an exercise program.
The format of the sessions, the study duration and the
weekly frequency of the program are organized in a
manner that ensures that this proposal is executable not
only for this project but also for future implementations
by communities.
Conclusion
This study is a randomized controlled trial (RCT) that
uses a self-management and exercise intervention strategy
along with glucosamine and chondroitin sulfate supple-
mentation. The protocol was specially designed according
to a carefully controlled methodology. The projected re-
sults will enable the implementation of a new combination
treatment for elderly patients with KOA.
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